Skip to Content

Sorafenib Accord 200 mg film-coated tablets

Licence status
Authorised: 09/11/2022
Active substances
Sorafenib Tosilate
Dosage Form
Film-coated tablet
Licence number
EU/1/22/1696/001
Licence holder
Accord Healthcare S.L.U.

Licence information

ATC code
L01 ANTINEOPLASTIC AGENTS, L01EX02 Sorafenib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal products on restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
09/11/2022